AtlasDigestiveDigestive diseases

Paralytic ileus and intestinal obstruction

3Curable in someAI-generated

Surgery cures some obstructions; ileus often resolves with supportive careAI-generated

Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

What's being tested now

2010: 1 trials started2015: 1 trials started2021: 1 trials started2023: 4 trials started2024: 4 trials started2025: 14 trials started2026: 9 trials started20102020202614

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

See all 32 active Ileus trials on Clin2 →

Where we are

AI-generated

This condition is curable in some, mainly when a mechanical obstruction like an adhesion, hernia, or tumor can be surgically corrected. Paralytic ileus, however, lacks a specific cure and usually resolves with bowel rest, fluids, and electrolyte support. No comprehensive burden data are available, but well-established knowledge suggests that survival and recovery have gradually improved over recent decades through better imaging, surgical technique, and supportive care. No single named milestone marks this progress. Research is still early: 33 trials have begun in the last five years, none yet in phase 3, and 32 remain active, so new therapies are not yet proven.

Can surgery cure all intestinal obstructions?
No. Surgery works mainly for mechanical blockages caused by adhesions, hernias, or tumors. For paralytic ileus, where the bowel stops contracting, there is no surgical fix; treatment focuses on supportive care and waiting for function to return.
Is paralytic ileus permanent?
Usually not. It often resolves within days to weeks with bowel rest, fluids, and electrolyte correction. In some cases it persists or recurs, but most people recover without a specific cure.
Are there new treatments in development?
Some trials are running. In the past five years, 33 studies started, but none have reached phase 3, meaning no new therapy has passed late-stage testing. 32 trials are still active, so evidence is limited.
Has survival improved over time?
Yes, gradual improvement is likely across recent decades due to better imaging, safer surgery, and improved care for critically ill patients. But without comprehensive data, we cannot quantify this progress.
What is the most important research milestone?
No single milestone stands out for this condition. Progress has been incremental, with advances in diagnosis and surgical technique. Ongoing trials aim to change that.

Related

Burden estimates: IHME Global Burden of Disease Study. Drug indications: ChEMBL (CC BY-SA). Trial data: ClinicalTrials.gov via Clin2. Velocity, acceleration, and turning points are computed by Clin2 — how this page is made. Treatability describes what medicine can do, not what is available everywhere. This page describes populations, not people, and is not medical advice.